S 919

  • New Jersey Senate Bill
  • 2020-2021 Regular Session
  • Introduced in Senate Jan 27, 2020
  • Senate
  • Assembly
  • Governor

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.


No votes to display


Jan 27, 2020


Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee

Bill Text

Bill Text Versions Format
Introduced Version HTML

Related Documents

Document Format
No related documents.


Data on Open States is updated periodically throughout the day from the official website of the New Jersey Legislature.

If you notice any inconsistencies with these official sources, feel free to file an issue.